Education
About Us
Working with TipRanks
Follow Us
USANA Health (USNA)
NYSE:USNA
USNA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$23.10 - $41.84
Previous CloseN/A
Volume19.92K
Average Volume (3M)130.13K
Market Cap
$555.46M
Enterprise Value$480.19M
Total Cash (Recent Filing)$179.61M
Total Debt (Recent Filing)$23.00M
Price to Earnings (P/E)16.9
Beta0.98
Next Earnings
Oct 28, 2025EPS Estimate
0.56Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.74
Shares Outstanding18,271,835
10 Day Avg. Volume104,700
30 Day Avg. Volume130,126
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.86
Enterprise Value/Revenue0.55
Enterprise Value/Gross Profit0.68
Enterprise Value/Ebitda5.24
Forecast
1Y Price Target
$34.00Price Target Upside11.84% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
USANA Health News
USNA FAQ
What was USANA Health’s price range in the past 12 months?
USANA Health lowest stock price was $23.10 and its highest was $41.84 in the past 12 months.
What is USANA Health’s market cap?
USANA Health’s market cap is $555.46M.
When is USANA Health’s upcoming earnings report date?
USANA Health’s upcoming earnings report date is Oct 28, 2025 which is in 70 days.
How were USANA Health’s earnings last quarter?
USANA Health released its earnings results on Jul 22, 2025. The company reported $0.74 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.2.
Is USANA Health overvalued?
According to Wall Street analysts USANA Health’s price is currently Undervalued.
Does USANA Health pay dividends?
USANA Health does not currently pay dividends.
What is USANA Health’s EPS estimate?
USANA Health’s EPS estimate is 0.56.
How many shares outstanding does USANA Health have?
USANA Health has 18,271,835 shares outstanding.
What happened to USANA Health’s price movement after its last earnings report?
USANA Health reported an EPS of $0.74 in its last earnings report, beating expectations of $0.54. Following the earnings report the stock price went up 12.369%.
Which hedge fund is a major shareholder of USANA Health?
Currently, no hedge funds are holding shares in USNA
USANA Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$34.00 (11.84% Upside)
$34.00 (11.84% Upside)
Blogger Sentiment
Bullish
USNA Sentiment 80%
Sector Average 73%
Sector Average 73%
Hedge Fund Trend
Increased
By 22.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $342.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.33%
12-Months-Change
Fundamentals
Return on Equity
6.54%
Trailing 12-Months
Asset Growth
16.33%
Trailing 12-Months
Company Description
USANA Health
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
USNA Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a positive sentiment with strong financial performance, successful strategic initiatives, and promising growth from recent acquisitions. However, there were challenges in the Chinese market and a decline in active customers. Despite these issues, the company is confident in its future outlook.View all USNA earnings summariesUSNA Stock 12 Month Forecast
Average Price Target
$34.00
▲(11.84% Upside)
Technical Analysis
Ownership Overview
41.10% Insiders
13.39% Mutual Funds
0.63% Other Institutional Investors
27.07% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---